-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AobQkoTjgF1Gu5JYwbbCHGfSqrktjbE7czl/puIrY8k5yjoax5/VIQrt8misFmOc SPgKO+f6LU+p95AFpcYufA== 0000728612-99-000017.txt : 19990217 0000728612-99-000017.hdr.sgml : 19990217 ACCESSION NUMBER: 0000728612-99-000017 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDITRUST CORP CENTRAL INDEX KEY: 0000314661 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 953520818 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-32774 FILM NUMBER: 99542954 BUSINESS ADDRESS: STREET 1: MEDITRUST CORP STREET 2: 197 FIRST AVE STE 100 CITY: NEEDHAM STATE: MA ZIP: 02194 BUSINESS PHONE: 7814336000 MAIL ADDRESS: STREET 1: MEDITRUST CORP STREET 2: 197 FIRST AVENUE SUITE 100 CITY: NEEDHAM STATE: MA ZIP: 02194 FORMER COMPANY: FORMER CONFORMED NAME: SANTA ANITA REALTY ENTERPRISES INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MERRILL LYNCH PIERCE FENNER & SMITH INC CENTRAL INDEX KEY: 0000728612 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: NORTH TOWER WORLD FINANCIAL CENTER CITY: NEW YORK STATE: NY ZIP: 10281-1323 BUSINESS PHONE: 2124496202 MAIL ADDRESS: STREET 1: WORLD FINANCIAL CENTER STREET 2: NORTH TOWER 23RD FL CITY: NEW YORK STATE: NY ZIP: 10281-1323 SC 13G 1 INITIAL - -------------------------------------------------------------------------------- OMB APPROVAL - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- OMB number 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response . . .14.90 - ------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Meditrust Corp. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - Paired Shares - -------------------------------------------------------------------------------- (Title Of Class of Securities) 58501T306 - -------------------------------------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ----------------------------------------------------------------------------- CUSIP NO. 58501T306 13G PAGE 2 OF 8 PAGES ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Merrill Lynch & Co., Inc. ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Joint Filing (a) (b) ------- ----------------------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF None -------------------------------------------------------- -------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH 8,415,000 -------------------------------------------------------- -------------------------------------------------------- 7 SOLE DISPOSITIVE POWER REPORTING PERSON WITH None -------------------------------------------------------- -------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 8,415,000 ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,415,000 ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.6% ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* HC, CO ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! ----------------------------------------------------------------------------- CUSIP NO. 58501T306 13G PAGE 3 OF 8 PAGES ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Merrill Lynch International ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* Joint Filing (a) (b) ------- ----------------------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF None -------------------------------------------------------- -------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH 8,415,000 -------------------------------------------------------- -------------------------------------------------------- 7 SOLE DISPOSITIVE POWER REPORTING PERSON WITH None -------------------------------------------------------- -------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 8,415,000 ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,415,000 ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.6% ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* BD, CO ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! SCHEDULE 13G Item 1 (a) Name of Issuer: Meditrust Corp. (the "Company") Item 1 (b) Address of Issuer's Principal Executive Offices: 197 First Ave. Suite 300 Needham Heights, MA 02194 Item 2 (a) Names of Person Filing: Merrill Lynch & Co., Inc. ("ML&Co.") Item 2 (b) Address of Principal Business Office, or, if None, Residence: Merrill Lynch & Co., Inc. World Financial Center, North Tower 250 Vesey Street New York, New York 10281 Item 2 (c) Citizenship: See Item 4 of Cover Pages Item 2 (d) Title of Class of Securities: See Cover Page Item 2 (e) CUSIP Number: See Cover Page Item 3 Merrill Lynch & Co., Inc. is a parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). Merrill Lynch International ("MLI"), a London-based broker-dealer in securities, is a member the International Securities Markets Association and its activities are regulated by the U.K. Securities and Futures Authority Limited and the London Stock Exchange. Item 4 Ownership (a) Amount Beneficially Owned: See Item 9 of Cover Pages. Pursuant to ss. 240.13d-4, ML&Co. and MLI disclaim beneficial ownership of the securities of the Company referred to herein, and the filing of this Schedule 13G shall not be construed as an admission that any such entity is, for the purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities of the Company covered by this statement, other than certain securities of the Company held in MLI proprietary accounts. Page 4 of 8 Pages (b) Percent of Class See Item 11 of Cover Pages (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote See Item 5 of Cover Pages (ii) shared power to vote or to direct the vote See Item 6 of Cover Pages (iii) sole power to dispose or to direct the disposition of See Item 7 of Cover Pages (iv) shared power to dispose or to direct the disposition of See Item 8 of Cover Pages Item 5 Ownership of Five Percent or Less of a Class. Not Applicable Item 6 Ownership of More than Five Percent on Behalf of Another Person. MLI, a reporting person on this Schedule G, has an interest that relates to more than 5% of the class of securities reported herein. Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. The relevant subsidiary of ML&Co. is Merrill Lynch International, a London based broker-dealer in securities which provides its customers with general investment banking, advisory, dealing and corporate finance services, organized under the laws of England and Wales. Merrill Lynch International is an indirect wholly owned subsidiary of ML&Co. and is the beneficial owner of 5.6% of the common stock of Meditrust Corp. Item 8 Identification and Classification of Members of the Group. Not Applicable Item 9 Notice of Dissolution of Group Not Applicable Page 5 of 8 Pages Item 10 Certification By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. Signature. After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 16, 1999 Merrill Lynch & Co., Inc. By: /s/Andrea Lowenthal Name: Andrea Lowenthal Title: Attorney-in-Fact* Date: February 16, 1999 Merrill Lynch International By: /s/ John J. McDermott, Jr. Name: John J. McDermott, Jr. Title: Attorney-in-Fact** * Executed pursuant to a Power of Attorney dated November 17, 1995, a copy of which is attached hereto as Exhibit A. ** Executed pursuant to a Power of Attorney dated February 16, 1999, a copy of which is attached hereto as Exhibit B. Exhibit A to Schedule 13G Power of Attorney The undersigned, Merrill Lynch & Co., Inc. (the "Corporation"), a corporation duly organized under the laws of Delaware, with its principal place of business at World Financial Center, North Tower, 250 Vesey Street, New York, New York 10281 does hereby make, constitute and appoint Richard B. Alsop, Richard D. Kreuder, Andrea Lowenthal, Gregory T. Russo, or any other individual from time to time elected or appointed as secretary or an assistant secretary of the Corporation, acting severally, each of whose address is Merrill Lynch & Co., Inc., World Financial Center, North Tower, 250 Vesey Street, New York, New York 10281, as its true and lawful attorneys-in-fact, for it and in its name, place and stead (i) to execute on behalf of the Corporation and cause to be filed and/or delivered, as required under Section 13(d) of the Securities Exchange Act of 1934 (the "Act") and the regulations thereunder, any number, as appropriate, of original, copies, or electronic filings of the Securities and Exchange Commission Schedule 13D or Schedule 13G Beneficial Ownership Reports (together with any amendments and joint filing agreements under Rule 13d-1(f) (1) of the Act, as may be required thereto) to be filed and/or delivered with respect to any equity security (as defined in Rule 13d-1(d) under the Act) beneficially owned by the undersigned and which must be reported by the undersigned pursuant to Section 13(d) of the Act and the regulations thereunder, (ii) to execute on behalf of the Corporation and cause to be filed and /or delivered, any number, as appropriate, of original, copies or electronic filings of any forms (including without limitation), Securities and Exchange Commission Forms 3, 4 and 5) required to be filed pursuant to Section 16 (a) of the Act and the regulations thereunder, and (iii) generally to take such other actions and perform such other things necessary to effectuate the foregoing as fully in all respects as if the undersigned could do if personally present. This Power of Attorney shall remain in effect until revoked, in writing, by the undersigned. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 17th day of November 1995. MERRILL LYNCH & CO., INC. By: /s/ David H. Komansky Name: David H. Komansky Title: President and Chief Operating Officer Exhibit B to Schedule 13G POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS that the undersigned, MERRILL LYNCH INTERNATIONAL, a company organised and existing under the laws of England and Wales, with its registered office at Ropemaker Place, 25 Ropemaker Street, London EC2Y 9LY, England (hereinafter referred to as the "Company") hereby appoints John J. McDermott, Jr. acting singly, with full power and authority on behalf of and in the name, place and stead of the Company to execute and cause to be filed and/or delivered, as required under Section 13(d) of the Securities and Exchange Act of 1934 (the "Act") and the regulations thereunder, any number, as appropriate, of original, copies or electronic filings of the U.S. Securities and Exchange Commission Schedule 13D or Schedule 13G Beneficial Ownership Reports (together with any amendments and joint filing agreements under Rule 13d-1(f)(1) of the Act, as may be required thereto) to be so filed and/or delivered with respect to any equity security (as defined in Rule 13d-1(d) under the Act) beneficially owned by the undersigned and which must be reported by the undersigned pursuant to Section 13(d) of the Act and the regulations thereunder. By this power, said attorney is hereby granted full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in connection with the performance of the foregoing authority, as fully and to all intents and purposes as the proper officer of the undersigned might or could do if personally present at the doing hereof. The undersigned hereby ratifies and confirms all that said attorney shall lawfully do or cause to be done by virtue hereof. This Power of Attorney is governed by and shall be construed in accordance with English law and shall expire on December 31, 1999. IN WITNESS WHEREOF this instrument has been executed by officers thereunto duly authorised, and the Common Seal of the Company has been affixed this 16th day of February 1999. MERRILL LYNCH INTERNATIONAL /s/ Costas P. Michaelides /s/ Debra A. Searle Costas P. Michaelides Debra A. Searle Director Assistant Company Secretary -----END PRIVACY-ENHANCED MESSAGE-----